Research Purposes Only

PT-141 10mg lyophilised research peptide vial β€” UK lab-tested, for research use only

Copper & Collagen Peptides

PT-141

Cβ‚…β‚€Hβ‚†β‚ˆN₁₄O₁₀

Key Research Findings

  • Characterisation of the cyclic heptapeptide with C-terminal carboxyl terminus.
  • Published MC3R / MC4R receptor-binding assay data.
  • In-vitro CNS receptor-distribution studies.

Overview

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin-receptor agonist with a free C-terminal carboxyl group. Supplied as a lyophilised powder for in-vitro research use only.

Mechanism of Action

Reported in published in-vitro studies as a melanocortin-receptor ligand active at MC3R and MC4R receptor-binding assays. Not intended for human or veterinary use.

Research Effects

MC3R / MC4R Receptor Binding

Extensive Research

Characterised in receptor-binding assays as a ligand of MC3R and MC4R melanocortin-receptor subtypes.

Receptor-Distribution Studies

Moderate Research

Published in-vitro studies report receptor-distribution profiles in cell-line and tissue assays.

MC1R Cross-Reactivity

Moderate Research

Receptor-selectivity studies report secondary MC1R binding under assay conditions tested.

Research Purposes Only β€” All information on this page is provided for scientific research purposes only. This product is not intended for human consumption, diagnosis, treatment, or prevention of any disease.

Quick Facts

Molecular FormulaCβ‚…β‚€Hβ‚†β‚ˆN₁₄O₁₀
Molecular Weight1025.17 g/mol
CAS Number189691-06-3
SequenceAc-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Half-Life~2.7 hours (animal pharmacokinetic data)
SolubilityWater (1 mg/mL)
Storageβˆ’20 Β°C
More in Copper & Collagen Peptides

Research Status Key

Extensive Research
Moderate Research
Preliminary Research

Related Peptides

How can we help?
Cart